Share This

Related Topics News -

     
 Detail   |   Print    Next page > 
     
神威藥業首季營業額11.2億人幣 按年跌6.1%
2024-05-06T  
《公司業績》神威藥業全年純利9.7億人幣升34.1% 末期息43分人幣
2024-03-28T  
《盈利預喜》神威藥業料去年純利升30%至36%
2024-03-07T  
《大行報告》中金:國指及科指檢討結果料對聯通及同程影響正面 22隻股份或符納入港股通
2024-02-20T  
十月稻田、鍋圈、藥明合聯及中旭未來漲9%-17% 中金料有望納入港股通
2024-02-16T  
《大行報告》中金:快手-W、太古地產、京東物流、小鵬-W、新東方-S、百濟神州及信達生物等符合「染藍」名單前列
2024-02-14T  
恆指升幅擴至逾300點 醫藥股普遍造好 金斯瑞及艾美升6%至8%
2024-01-11T  
醫藥股普遍捱沽 泰格、三葉草及來凱挫約9.5%-10%
2023-12-04T  
京東-SW與神威藥業簽署戰略合作協議
2023-12-01T  
醫藥股普遍隨大市造好 來凱、開拓及百心安漲逾9%-25%
2023-11-20T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.